The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Stopped pending study amendment/re-design
Conditions
- Gastrointestinal Cancer
- Head and Neck Cancer
- Dihydropyrimidine Dehydrogenase Deficiency
- UGT1A1 Gene Mutation
- Breast Cancer
Interventions
- OTHER: Availability of clinical decision support based on pharmacogenomic results.
Sponsor
University of Chicago
Collaborators